Zbtb7 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zbtb7" in English language version.

refsWebsite

Global rank English rank

13nih.gov

4^th place

10doi.org

2^nd place

4worldcat.org

5^th place

2semanticscholar.org

11^th place

8^th place

1phosphosite.org

low place

1uniprot.org

5,673^rd place

6,418^th place

1harvard.edu

18^th place

17^th place

1tandfonline.com

507^th place

429^th place

1gamespot.com

125^th place

104^th place

doi.org

Maeda, Takahiro; Hobbs, Robin M.; Pandolfi, Pier Paolo (2005). "The Transcription Factor Pokemon: A New Key Player in Cancer Pathogenesis". Cancer Research. 65 (19): 8575–8578. doi:10.1158/0008-5472.CAN-05-1055. PMID 16204018.
Guo, Changcheng; Xiong, Dabo; Yang, Bin; Zhang, Haiming; Gu, Wenyu; Liu, Min; Yao, Xudong; Zheng, Junhua; Peng, Bo (October 2017). "The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder". Oncology Letters. 14 (4): 4857–4862. doi:10.3892/ol.2017.6814. PMC 5649710. PMID 29085492.
Kukita, A; Kukita, T; Ouchida, M; Maeda, H; Yatsuki, H; Kohashi, O (15 September 1999). "Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis". Blood. 94 (6): 1987–97. doi:10.1182/blood.V94.6.1987. PMID 10477728.
Komiya, Yuko; Akiyama, Hirotada; Sakumoto, Ryuji; Tashiro, Fumio (February 2014). "FBI1/Akirin2 promotes tumorigenicity and metastasis of Lewis lung carcinoma cells". Biochemical and Biophysical Research Communications. 444 (3): 382–386. doi:10.1016/j.bbrc.2014.01.064. PMID 24468084.
Jiang, Yuyang (23 March 2012). "Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: Implications for the role of Zbtb7 in cell cycle regulation". Molecular Medicine Reports. 5 (6): 1475–80. doi:10.3892/mmr.2012.846. PMID 22447046.
Wang, Zexin; Zhao, Xilan; Wang, Wei; Liu, Yishu; Li, Yanyan; Gao, Junyong; Wang, Cancan; Zhou, Meiyu; Liu, Ruyan; Xu, Guofa; Zhou, Qi (2018-08-10). "ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway". International Journal of Oncology. 53 (5): 2102–2110. doi:10.3892/ijo.2018.4521. ISSN 1019-6439. PMID 30106136.
Maeda, Takahiro; Hobbs, Robin M.; Merghoub, Taha; Guernah, Ilhem; Zelent, Arthur; Cordon-Cardo, Carlos; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo (January 2005). "Role of the proto-oncogene Pokemon in cellular transformation and ARF repression". Nature. 433 (7023): 278–285. Bibcode:2005Natur.433..278M. doi:10.1038/nature03203. PMID 15662416. S2CID 4308742.
Qu, Hongyan; Qu, Danni; Chen, Fuhui; Zhang, Zhenyu; Liu, Baogang; Liu, Haifeng (June 2010). "ZBTB7 Overexpression Contributes to Malignancy in Breast Cancer". Cancer Investigation. 28 (6): 672–678. doi:10.3109/07357901003631007. ISSN 0735-7907. PMID 20394500. S2CID 26171423.
Guo, Changcheng; Xiong, Dabo; Yang, Bin; Zhang, Haiming; Gu, Wenyu; Liu, Min; Yao, Xudong; Zheng, Junhua; Peng, Bo (October 2017). "The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder". Oncology Letters. 14 (4): 4857–4862. doi:10.3892/ol.2017.6814. ISSN 1792-1074. PMC 5649710. PMID 29085492.
Wang, Lihui; Li, Qi; Ye, Zhuo; Qiao, Baoping (2019-09-23). "ZBTB7/miR-137 Autoregulatory Circuit Promotes the Progression of Renal Carcinoma". Oncology Research. 27 (9): 1007–1014. doi:10.3727/096504018X15231148037228. ISSN 0965-0407. PMC 7848413. PMID 29673422.

gamespot.com

Brendan Sinclair (2005-12-19). "Pokémon USA threatens to sue cancer researchers". GameSpot. Retrieved 2016-01-31.

harvard.edu

ui.adsabs.harvard.edu

Maeda, Takahiro; Hobbs, Robin M.; Merghoub, Taha; Guernah, Ilhem; Zelent, Arthur; Cordon-Cardo, Carlos; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo (January 2005). "Role of the proto-oncogene Pokemon in cellular transformation and ARF repression". Nature. 433 (7023): 278–285. Bibcode:2005Natur.433..278M. doi:10.1038/nature03203. PMID 15662416. S2CID 4308742.

nih.gov

pubmed.ncbi.nlm.nih.gov

Maeda, Takahiro; Hobbs, Robin M.; Pandolfi, Pier Paolo (2005). "The Transcription Factor Pokemon: A New Key Player in Cancer Pathogenesis". Cancer Research. 65 (19): 8575–8578. doi:10.1158/0008-5472.CAN-05-1055. PMID 16204018.
Guo, Changcheng; Xiong, Dabo; Yang, Bin; Zhang, Haiming; Gu, Wenyu; Liu, Min; Yao, Xudong; Zheng, Junhua; Peng, Bo (October 2017). "The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder". Oncology Letters. 14 (4): 4857–4862. doi:10.3892/ol.2017.6814. PMC 5649710. PMID 29085492.
Kukita, A; Kukita, T; Ouchida, M; Maeda, H; Yatsuki, H; Kohashi, O (15 September 1999). "Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis". Blood. 94 (6): 1987–97. doi:10.1182/blood.V94.6.1987. PMID 10477728.
Komiya, Yuko; Akiyama, Hirotada; Sakumoto, Ryuji; Tashiro, Fumio (February 2014). "FBI1/Akirin2 promotes tumorigenicity and metastasis of Lewis lung carcinoma cells". Biochemical and Biophysical Research Communications. 444 (3): 382–386. doi:10.1016/j.bbrc.2014.01.064. PMID 24468084.
Jiang, Yuyang (23 March 2012). "Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: Implications for the role of Zbtb7 in cell cycle regulation". Molecular Medicine Reports. 5 (6): 1475–80. doi:10.3892/mmr.2012.846. PMID 22447046.
Wang, Zexin; Zhao, Xilan; Wang, Wei; Liu, Yishu; Li, Yanyan; Gao, Junyong; Wang, Cancan; Zhou, Meiyu; Liu, Ruyan; Xu, Guofa; Zhou, Qi (2018-08-10). "ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway". International Journal of Oncology. 53 (5): 2102–2110. doi:10.3892/ijo.2018.4521. ISSN 1019-6439. PMID 30106136.
Maeda, Takahiro; Hobbs, Robin M.; Merghoub, Taha; Guernah, Ilhem; Zelent, Arthur; Cordon-Cardo, Carlos; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo (January 2005). "Role of the proto-oncogene Pokemon in cellular transformation and ARF repression". Nature. 433 (7023): 278–285. Bibcode:2005Natur.433..278M. doi:10.1038/nature03203. PMID 15662416. S2CID 4308742.
Qu, Hongyan; Qu, Danni; Chen, Fuhui; Zhang, Zhenyu; Liu, Baogang; Liu, Haifeng (June 2010). "ZBTB7 Overexpression Contributes to Malignancy in Breast Cancer". Cancer Investigation. 28 (6): 672–678. doi:10.3109/07357901003631007. ISSN 0735-7907. PMID 20394500. S2CID 26171423.
Guo, Changcheng; Xiong, Dabo; Yang, Bin; Zhang, Haiming; Gu, Wenyu; Liu, Min; Yao, Xudong; Zheng, Junhua; Peng, Bo (October 2017). "The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder". Oncology Letters. 14 (4): 4857–4862. doi:10.3892/ol.2017.6814. ISSN 1792-1074. PMC 5649710. PMID 29085492.
Wang, Lihui; Li, Qi; Ye, Zhuo; Qiao, Baoping (2019-09-23). "ZBTB7/miR-137 Autoregulatory Circuit Promotes the Progression of Renal Carcinoma". Oncology Research. 27 (9): 1007–1014. doi:10.3727/096504018X15231148037228. ISSN 0965-0407. PMC 7848413. PMID 29673422.

ncbi.nlm.nih.gov

Guo, Changcheng; Xiong, Dabo; Yang, Bin; Zhang, Haiming; Gu, Wenyu; Liu, Min; Yao, Xudong; Zheng, Junhua; Peng, Bo (October 2017). "The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder". Oncology Letters. 14 (4): 4857–4862. doi:10.3892/ol.2017.6814. PMC 5649710. PMID 29085492.
Guo, Changcheng; Xiong, Dabo; Yang, Bin; Zhang, Haiming; Gu, Wenyu; Liu, Min; Yao, Xudong; Zheng, Junhua; Peng, Bo (October 2017). "The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder". Oncology Letters. 14 (4): 4857–4862. doi:10.3892/ol.2017.6814. ISSN 1792-1074. PMC 5649710. PMID 29085492.
Wang, Lihui; Li, Qi; Ye, Zhuo; Qiao, Baoping (2019-09-23). "ZBTB7/miR-137 Autoregulatory Circuit Promotes the Progression of Renal Carcinoma". Oncology Research. 27 (9): 1007–1014. doi:10.3727/096504018X15231148037228. ISSN 0965-0407. PMC 7848413. PMID 29673422.

phosphosite.org

"FBI1 (Human)".

semanticscholar.org

api.semanticscholar.org

Maeda, Takahiro; Hobbs, Robin M.; Merghoub, Taha; Guernah, Ilhem; Zelent, Arthur; Cordon-Cardo, Carlos; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo (January 2005). "Role of the proto-oncogene Pokemon in cellular transformation and ARF repression". Nature. 433 (7023): 278–285. Bibcode:2005Natur.433..278M. doi:10.1038/nature03203. PMID 15662416. S2CID 4308742.
Qu, Hongyan; Qu, Danni; Chen, Fuhui; Zhang, Zhenyu; Liu, Baogang; Liu, Haifeng (June 2010). "ZBTB7 Overexpression Contributes to Malignancy in Breast Cancer". Cancer Investigation. 28 (6): 672–678. doi:10.3109/07357901003631007. ISSN 0735-7907. PMID 20394500. S2CID 26171423.

tandfonline.com

Qu, Hongyan; Qu, Danni; Chen, Fuhui; Zhang, Zhenyu; Liu, Baogang; Liu, Haifeng (June 2010). "ZBTB7 Overexpression Contributes to Malignancy in Breast Cancer". Cancer Investigation. 28 (6): 672–678. doi:10.3109/07357901003631007. ISSN 0735-7907. PMID 20394500. S2CID 26171423.

uniprot.org

"ZBTB7A - Zinc finger and BTB domain-containing protein 7A - Homo sapiens (Human) - ZBTB7A gene & protein". www.uniprot.org. Retrieved 2021-04-25.

worldcat.org

Wang, Zexin; Zhao, Xilan; Wang, Wei; Liu, Yishu; Li, Yanyan; Gao, Junyong; Wang, Cancan; Zhou, Meiyu; Liu, Ruyan; Xu, Guofa; Zhou, Qi (2018-08-10). "ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway". International Journal of Oncology. 53 (5): 2102–2110. doi:10.3892/ijo.2018.4521. ISSN 1019-6439. PMID 30106136.
Qu, Hongyan; Qu, Danni; Chen, Fuhui; Zhang, Zhenyu; Liu, Baogang; Liu, Haifeng (June 2010). "ZBTB7 Overexpression Contributes to Malignancy in Breast Cancer". Cancer Investigation. 28 (6): 672–678. doi:10.3109/07357901003631007. ISSN 0735-7907. PMID 20394500. S2CID 26171423.
Guo, Changcheng; Xiong, Dabo; Yang, Bin; Zhang, Haiming; Gu, Wenyu; Liu, Min; Yao, Xudong; Zheng, Junhua; Peng, Bo (October 2017). "The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder". Oncology Letters. 14 (4): 4857–4862. doi:10.3892/ol.2017.6814. ISSN 1792-1074. PMC 5649710. PMID 29085492.
Wang, Lihui; Li, Qi; Ye, Zhuo; Qiao, Baoping (2019-09-23). "ZBTB7/miR-137 Autoregulatory Circuit Promotes the Progression of Renal Carcinoma". Oncology Research. 27 (9): 1007–1014. doi:10.3727/096504018X15231148037228. ISSN 0965-0407. PMC 7848413. PMID 29673422.